+
データを開く
-
基本情報
登録情報 | ![]() | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
タイトル | ATR-ATRIP bound with RP-3500 | |||||||||
![]() | ||||||||||
![]() |
| |||||||||
![]() | ATR-ATRIP inhibitor / CELL CYCLE | |||||||||
機能・相同性 | ![]() ATR-ATRIP complex / establishment of RNA localization to telomere / positive regulation of telomerase catalytic core complex assembly / MutSalpha complex binding / establishment of protein-containing complex localization to telomere / nuclear membrane disassembly / MutLalpha complex binding / response to arsenic-containing substance / regulation of double-strand break repair / mitotic G2/M transition checkpoint ...ATR-ATRIP complex / establishment of RNA localization to telomere / positive regulation of telomerase catalytic core complex assembly / MutSalpha complex binding / establishment of protein-containing complex localization to telomere / nuclear membrane disassembly / MutLalpha complex binding / response to arsenic-containing substance / regulation of double-strand break repair / mitotic G2/M transition checkpoint / positive regulation of DNA damage response, signal transduction by p53 class mediator / nucleobase-containing compound metabolic process / protein localization to chromosome, telomeric region / HDR through Single Strand Annealing (SSA) / K63-linked polyubiquitin modification-dependent protein binding / Impaired BRCA2 binding to RAD51 / negative regulation of DNA replication / replication fork processing / site of DNA damage / Presynaptic phase of homologous DNA pairing and strand exchange / replicative senescence / Regulation of HSF1-mediated heat shock response / interstrand cross-link repair / Activation of ATR in response to replication stress / response to mechanical stimulus / regulation of cellular response to heat / positive regulation of telomere maintenance via telomerase / Meiotic synapsis / telomere maintenance / DNA damage checkpoint signaling / TP53 Regulates Transcription of DNA Repair Genes / Fanconi Anemia Pathway / G2/M DNA damage checkpoint / cellular response to gamma radiation / PML body / cellular response to UV / nuclear envelope / double-strand break repair / peptidyl-serine phosphorylation / chromosome / Processing of DNA double-strand break ends / protein autophosphorylation / Regulation of TP53 Activity through Phosphorylation / eukaryotic translation initiation factor 2alpha kinase activity / 3-phosphoinositide-dependent protein kinase activity / DNA-dependent protein kinase activity / ribosomal protein S6 kinase activity / histone H3S10 kinase activity / histone H2AXS139 kinase activity / histone H3S28 kinase activity / histone H4S1 kinase activity / histone H2BS14 kinase activity / histone H3T3 kinase activity / histone H2AS121 kinase activity / Rho-dependent protein serine/threonine kinase activity / histone H2BS36 kinase activity / histone H3S57 kinase activity / histone H2AT120 kinase activity / AMP-activated protein kinase activity / histone H2AS1 kinase activity / histone H3T6 kinase activity / histone H3T11 kinase activity / histone H3T45 kinase activity / DNA replication / non-specific serine/threonine protein kinase / protein kinase activity / response to xenobiotic stimulus / protein serine kinase activity / DNA repair / protein serine/threonine kinase activity / DNA damage response / Golgi apparatus / DNA binding / nucleoplasm / ATP binding / nucleus 類似検索 - 分子機能 | |||||||||
生物種 | ![]() | |||||||||
手法 | 単粒子再構成法 / クライオ電子顕微鏡法 / 解像度: 3.79 Å | |||||||||
![]() | Wang G | |||||||||
資金援助 | ![]()
| |||||||||
![]() | ![]() タイトル: Molecular architecture and inhibition mechanism of human ATR-ATRIP. 著者: Guangxian Wang / Po Wang / Zexuan Zheng / Qingjun Zhang / Chenchen Xu / Xinyi Xu / Lingfei Jian / Zhanpeng Zhao / Gang Cai / Xuejuan Wang / ![]() 要旨: The ataxia telangiectasia-mutated and Rad3-related (ATR) kinase is a master regulator of DNA damage response and replication stress in humans. Targeting ATR is the focus of oncology drug pipelines ...The ataxia telangiectasia-mutated and Rad3-related (ATR) kinase is a master regulator of DNA damage response and replication stress in humans. Targeting ATR is the focus of oncology drug pipelines with a number of potent, selective ATR inhibitors currently in clinical development. Here, we determined the cryo-EM structures of the human ATR-ATRIP complex in the presence of VE-822 and RP-3500, two ATR inhibitors currently in Phase II clinical trials, achieving an overall resolution of approximately 3 Å. These structures yield a near-complete atomic model of the ATR-ATRIP complex, revealing subunit stoichiometry, intramolecular and intermolecular interactions, and critical regulatory sites including an insertion in the PIKK regulatory domain (PRD). Structural comparison provides insights into the modes of action and selectivity of ATR inhibitors. The divergent binding modes near the solvent side and in the rear pocket area of VE-822 and RP-3500, particularly their disparate binding orientations, lead to varying conformational changes in the active site. Surprisingly, one ATR-ATRIP complex binds four VE-822 molecules, with two in the ATR active site and two at the ATR-ATR dimer interface. The binding and selectivity of RP-3500 depend on two bound water molecules, which may be further enhanced by the substitution of these bound waters. Our study provides a structural framework for understanding ATR regulation and holds promise for assisting future efforts in rational drug design targeting ATR. | |||||||||
履歴 |
|
-
構造の表示
添付画像 |
---|
-
ダウンロードとリンク
-EMDBアーカイブ
マップデータ | ![]() | 204.2 MB | ![]() | |
---|---|---|---|---|
ヘッダ (付随情報) | ![]() ![]() | 18.4 KB 18.4 KB | 表示 表示 | ![]() |
画像 | ![]() | 126.3 KB | ||
Filedesc metadata | ![]() | 7.6 KB | ||
その他 | ![]() ![]() | 200.9 MB 200.9 MB | ||
アーカイブディレクトリ | ![]() ![]() | HTTPS FTP |
-関連構造データ
関連構造データ | ![]() 9l4dMC ![]() 9l40C ![]() 9l43C ![]() 9l45C ![]() 9l46C ![]() 9l4bC ![]() 9l4cC ![]() 9l4fC M: このマップから作成された原子モデル C: 同じ文献を引用 ( |
---|---|
類似構造データ | 類似検索 - 機能・相同性 ![]() |
-
リンク
EMDBのページ | ![]() ![]() |
---|---|
「今月の分子」の関連する項目 |
-
マップ
ファイル | ![]() | ||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
投影像・断面図 | 画像のコントロール
画像は Spider により作成 | ||||||||||||||||||||||||||||||||||||
ボクセルのサイズ | X=Y=Z: 0.82 Å | ||||||||||||||||||||||||||||||||||||
密度 |
| ||||||||||||||||||||||||||||||||||||
対称性 | 空間群: 1 | ||||||||||||||||||||||||||||||||||||
詳細 | EMDB XML:
|
-添付データ
-ハーフマップ: #2
ファイル | emd_62811_half_map_1.map | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
投影像・断面図 |
| ||||||||||||
密度ヒストグラム |
-ハーフマップ: #1
ファイル | emd_62811_half_map_2.map | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
投影像・断面図 |
| ||||||||||||
密度ヒストグラム |
-
試料の構成要素
-全体 : ATR-ATRIP
全体 | 名称: ATR-ATRIP |
---|---|
要素 |
|
-超分子 #1: ATR-ATRIP
超分子 | 名称: ATR-ATRIP / タイプ: cell / ID: 1 / 親要素: 0 / 含まれる分子: #1-#2 |
---|---|
由来(天然) | 生物種: ![]() |
-分子 #1: Serine/threonine-protein kinase ATR
分子 | 名称: Serine/threonine-protein kinase ATR / タイプ: protein_or_peptide / ID: 1 / コピー数: 2 / 光学異性体: LEVO / EC番号: non-specific serine/threonine protein kinase |
---|---|
由来(天然) | 生物種: ![]() |
分子量 | 理論値: 301.001938 KDa |
組換発現 | 生物種: ![]() |
配列 | 文字列: LASMIPALRE LGSATPEEYN TVVQKPRQIL CQFIDRILTD VNVVAVELVK KTDSQPTSVM LLDFIQHIMK SSPLMFVNVS GSHEAKGSC IEFSNWIITR LLRIAATPSC HLLHKKICEV ICSLLFLFKS KSPAIFGVLT KELLQLFEDL VYLHRRNVMG H AVEWPVVM ...文字列: LASMIPALRE LGSATPEEYN TVVQKPRQIL CQFIDRILTD VNVVAVELVK KTDSQPTSVM LLDFIQHIMK SSPLMFVNVS GSHEAKGSC IEFSNWIITR LLRIAATPSC HLLHKKICEV ICSLLFLFKS KSPAIFGVLT KELLQLFEDL VYLHRRNVMG H AVEWPVVM SRFLSQLDEH MGYLQSAPLQ LMSMQNLEFI EVTLLMVLTR IIAIVFFRRQ ELLLWQIGCV LLEYGSPKIK SL AISFLTE LFQLGGLPAQ PASTFFSSFL ELLKHLVEMD TDQLKLYEEP LSKLIKTLFP FEAEAYRNIE PVYLNMLLEK LCV MFEDGV LMRLKSDLLK AALCHLLQYF LKFVPAGYES ALQVRKVYVR NICKALLDVL GIEVDAEYLL GPLYAALKME SMEI IEEIQ CQTQQENLSS NSDGISPKRR RLSSSLNPSK RAPKQTEEIK HVDMNQKSIL WSALKQKAES LQISLEYSGL KNPVI EMLE GIAVVLQLTA LCTVHCSHQN MNCRTFKDCQ HKSKKKPSVV ITWMSLDFYT KVLKSCRSLL ESVQKLDLEA TIDKVV KIY DALIYMQVNS SFEDHILEDL CGMLSLPWIY SHSDDGCLKL TTFAANLLTL SCRISDSYSP QAQSRCVFLL TLFPRRI FL EWRTAVYNWA LQSSHEVIRA SCVSGFFILL QQQNSCNRVP KILIDKVKDD SDIVKKEFAS ILGQLVCTLH GMFYLTSS L TEPFSEHGHV DLFCRNLKAT SQHECSSSQL KASVCKPFLF LLKKKIPSPV KLAFIDNLHH LCKHLDFRED ETDVKAVLG TLLNLMEDPD KDVRVAFSGN IKHILESLDS EDGFIKELFV LRMKEAYTHA QISRNNELKD TLILTTGDIG RAAKGDLVPF ALLHLLHCL LSKSASVSGA AYTEIRALVA AKSVKLQSFF SQYKKPICQF LVESLHSSQM TALPNTPCQN ADVRKQDVAH Q REMALNTL SEIANVFDFP DLNRFLTRTL QVLLPDLAAK ASPAASALIR TLGKQLNVNR REILINNFKY IFSHLVCSCS KD ELERALH YLKNETEIEL GSLLRQDFQG LHNELLLRIG EHYQQVFNGL SILASFASSD DPYQGPRDII SPELMADYLQ PKL LGILAF FNMQLLSSSV GIEDKKMALN SLMSLMKLMG PKHVSSVRVK MMTTLRTGLR FKDDFPELCC RAWDCFVRCL DHAC LGSLL SHVIVALLPL IHIQPKETAA IFHYLIIENR DAVQDFLHEI YFLPDHPELK KIKAVLQEYR KETSESTDLQ TTLQL SMKA IQHENVDVRI HALTSLKETL YKNQEKLIKY ATDSETVEPI ISQLVTVLLK GCQDANSQAR LLCGECLGEL GAIDPG RLD FSTTETQGKD FTFVTGVEDS SFAYGLLMEL TRAYLAYADN SRAQDSAAYA IQELLSIYDC REMETNGPGH QLWRRFP EH VREILEPHLN TRYKSSQKST DWSGVKKPIY LSKLGSNFAE WSASWAGYLI TKVRHDLASK IFTCCSIMMK HDFKVTIY L LPHILVYVLL GCNQEDQQEV YAEIMAVLKH DDQHTINTQD IASDLCQLST QTVFSMLDHL TQWARHKFQA LKAEKCPHS KSNRNKVDSM VSTVDYEDYQ SVTRFLDLIP QDTLAVASFR SKAYTRAVMH FESFITEKKQ NIQEHLGFLQ KLYAAMHEPD GVAGVSAIR KAEPSLKEQI LEHESLGLLR DATACYDRAI QLEPDQIIHY HGVVKSMLGL GQLSTVITQV NGVHANRSEW T DELNTYRV EAAWKLSQWD LVENYLAADG KSTTWSVRLG QLLLSAKKRD ITAFYDSLKL VRAEQIVPLS AASFERGSYQ RG YEYIVRL HMLCELEHSI KPLFQHSPGD SSQEDSLNWV ARLEMTQNSY RAKEPILALR RALLSLNKRP DYNEMVGECW LQS ARVARK AGHHQTAYNA LLNAGESRLA ELYVERAKWL WSKGDVHQAL IVLQKGVELC FPENETPPEG KNMLIHGRAM LLVG RFMEE TANFESNAIM KKYKDVTACL PEWEDGHFYL AKYYDKLMPM VTDNKMEKQG DLIRYIVLHF GRSLQYGNQF IYQSM PRML TLWLDYGTKA YEWEKAGRSD RVQMRNDLGK INKVITEHTN YLAPYQFLTA FSQLISRICH SHDEVFVVLM EIIAKV FLA YPQQAMWMMT AVSKSSYPMR VNRCKEILNK AIHMKKSLEK FVGDATRLTD KLLELCNKPV DGSSSTLSMS THFKMLK KL VEEATFSEIL IPLQSVMIPT LPSILGTHAN HASHEPFPGH WAYIAGFDDM VEILASLQKP KKISLKGSDG KFYIMMCK P KDDLRKDCRL MEFNSLINKC LRKDAESRRR ELHIRTYAVI PLNDECGIIE WVNNTAGLRP ILTKLYKEKG VYMTGKELR QCMLPKSAAL SEKLKVFREF LLPRHPPIFH EWFLRTFPDP TSWYSSRSAY CRSTAVMSMV GYILGLGDRH GENILFDSLT GECVHVDFN CLFNKGETFE VPEIVPFRLT HNMVNGMGPM GTEGLFRRAC EVTMRLMRDQ REPLMSVLKT FLHDPLVEWS K PVKGHSKA PLNETGEVVN EKAKTHVLDI EQRLQGVIKT RNRVTGLPLS IEGHVHYLIQ EATDENLLCQ MYLGWTPYM UniProtKB: Serine/threonine-protein kinase ATR |
-分子 #2: ATR-interacting protein
分子 | 名称: ATR-interacting protein / タイプ: protein_or_peptide / ID: 2 / コピー数: 2 / 光学異性体: LEVO |
---|---|
由来(天然) | 生物種: ![]() |
分子量 | 理論値: 52.802465 KDa |
組換発現 | 生物種: ![]() |
配列 | 文字列: WRQRSNTQGS ILINLLLKQP LIPGSSLSLC HLLSSSSESP AGTPLQPPGF GSTLAGMSGL RTTGSYDGSF SLSALREAQN LAFTGLNLV ARNECSRDGD PAEGGRRAFP LCQLPGAVHF LPLVQFFIGL HCQALQDLAA AKRSGAPGDS PTHSSCVSSG V ETNPEDSV ...文字列: WRQRSNTQGS ILINLLLKQP LIPGSSLSLC HLLSSSSESP AGTPLQPPGF GSTLAGMSGL RTTGSYDGSF SLSALREAQN LAFTGLNLV ARNECSRDGD PAEGGRRAFP LCQLPGAVHF LPLVQFFIGL HCQALQDLAA AKRSGAPGDS PTHSSCVSSG V ETNPEDSV CILEGFSVTA LSILQHLVCH SGAVVSLLLS GVGADSAAGE GNRSLVHRLS DGDMTSALRG VADDQGQHPL LK MLLHLLA FSSAATGHLQ ASVLTQCLKV LVKLAENTSC DFLPRFQCVF QVLPKCLSPE TPLPSVLLAV ELLSLLADHD QLA PQLCSH SEGCLLLLLY MYITSRPDRV ALETQWLQLE QEVVWLLAKL GVQSPLPPVT GSNCQCNVEV VRALTVMLHR QWLT VRRAG GPPRTDQQRR TVRCLRDTVL LLHGLSQKDK LFMMHCVEVL HQFDQVMPGV SMLIRGLPDV TDCEEAALDD LCAAE TDVE DPEVECG UniProtKB: ATR-interacting protein |
-分子 #3: RP-3500
分子 | 名称: RP-3500 / タイプ: ligand / ID: 3 / コピー数: 2 / 式: A1EIK |
---|---|
分子量 | 理論値: 410.47 Da |
-分子 #4: ZINC ION
分子 | 名称: ZINC ION / タイプ: ligand / ID: 4 / コピー数: 1 / 式: ZN |
---|---|
分子量 | 理論値: 65.409 Da |
-実験情報
-構造解析
手法 | クライオ電子顕微鏡法 |
---|---|
![]() | 単粒子再構成法 |
試料の集合状態 | particle |
-
試料調製
緩衝液 | pH: 7.5 |
---|---|
凍結 | 凍結剤: ETHANE |
-
電子顕微鏡法
顕微鏡 | TFS KRIOS |
---|---|
撮影 | フィルム・検出器のモデル: GATAN K3 (6k x 4k) / 平均電子線量: 50.0 e/Å2 |
電子線 | 加速電圧: 300 kV / 電子線源: ![]() |
電子光学系 | 照射モード: FLOOD BEAM / 撮影モード: BRIGHT FIELD / 最大 デフォーカス(公称値): 2.5 µm / 最小 デフォーカス(公称値): 1.5 µm |
実験機器 | ![]() モデル: Titan Krios / 画像提供: FEI Company |